E

Eupraxia Pharmaceuticals
D

EPRX

8.00500
USD
0.04
(0.44%)
مغلق
حجم التداول
16,825
الربح لكل سهم
-1
العائد الربحي
-
P/E
-9
حجم السوق
466,335,085
أصول ذات صلة المقالات

العنوان: Eupraxia Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.